Balance sheet of Suven Life Sciences is strong.
It shouldn't have solvency or liquidity issues.

Yes, The debt of Suven Life Sciences is increasing.
Latest debt of Suven Life Sciences is -₹92.49 Crs as of Sep-24.
This is greater than Mar-24 when it was -₹327.94 Crs.

The profit is oscillating.
The profit of Suven Life Sciences is -₹143.34 Crs for TTM, -₹105.08 Crs for Mar 2024 and -₹118.27 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Suven Life Sciences latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly productive assets like Plant & Machinery and unproductive assets like Cash & Short Term Investments, Capital Work in Progress, Inventory, Accounts Receivable